ZAN-66786-66104
4 vaccinations
3 coded responses
49 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-14
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-29
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
-
2021-04-21
Survey response — 3 months, dose 2MedDRA: Blood thyroid stimulating hormone increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: My TSH levels changed from .47 to 4.19 between two days before my second dose and 6 weeks after. My endocrinologist increased my medication and Im now back at 2.4.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-21
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2021-10-05
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
-
2021-10-11
Survey response — days 1–6 daily, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: Common coldMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Survey response — day 7, dose 3MedDRA: Nasopharyngitis — Feeling: FairFree text: Common coldMedDRA releases: 2024-11 · check-in free text available
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-18
- 2022-01-04
- 2022-02-19
- 2022-04-05
-
2022-09-23
Dose 4 — ModernaCo-administered: Flu
-
2022-09-24
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-25
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2022-09-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-29
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-12-23
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-23 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-21 | Unsuccessful |
Free text
Release 7 — 3 months, dose 2
Symptoms: My TSH levels changed from .47 to 4.19 between two days before my second dose and 6 weeks after. My endocrinologist increased my medication and Im now back at 2.4.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Common cold
Release 10 — day 7, dose 3
Systemic reaction (other): Common cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood thyroid stimulating hormone increased | ✓ | ✓ | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release